Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Fiore

Showing results (391-400 of 421) with videos related to

Pageof 43
Sort By:
Annals of Surgery|April 11, 2017
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working GroupAndrea J MacNeill, Alessandro Gronchi, Rosalba Miceli, et al.
Annals of Surgical Oncology|May 15, 2025
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) CollaborationStijn J C van der Burg, Marco Fiore, Piotr Rutkowski, et al.
Cancers|February 9, 2021
Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study ProtocolDide den Hollander, Marco Fiore, Javier Martin-Broto, et al.
Journal of Clinical Medicine|November 27, 2021
Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied GroupIlse van Eck, Dide den Hollander, Emma Lidington, et al.
Annals of Surgical Oncology|June 14, 2013
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experiencePiotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2020
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)Gabriella Ferrandina, Cynthia Aristei, Pietro Raimondo Biondetti, et al.
Eclinicalmedicine|January 1, 2020
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivorsDario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
Eclinicalmedicine|June 16, 2025
Defining benchmark values for outcomes of comprehensive resection of primary retroperitoneal liposarcoma: a retrospective multicenter studyFabio Tirotta, Marco Fiore, Sylvie Bonvalot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWGChandrajit P Raut, Dario Callegaro, Rosalba Miceli, et al.
Annals of Surgical Oncology|January 3, 2021
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Pageof 43

Showing results (391-400 of 421) with videos related to

Sort By:
Pageof 43
Annals of Surgery|April 11, 2017
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working GroupAndrea J MacNeill, Alessandro Gronchi, Rosalba Miceli, et al.
Annals of Surgical Oncology|May 15, 2025
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) CollaborationStijn J C van der Burg, Marco Fiore, Piotr Rutkowski, et al.
Cancers|February 9, 2021
Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study ProtocolDide den Hollander, Marco Fiore, Javier Martin-Broto, et al.
Journal of Clinical Medicine|November 27, 2021
Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied GroupIlse van Eck, Dide den Hollander, Emma Lidington, et al.
Annals of Surgical Oncology|June 14, 2013
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experiencePiotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2020
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)Gabriella Ferrandina, Cynthia Aristei, Pietro Raimondo Biondetti, et al.
Eclinicalmedicine|January 1, 2020
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivorsDario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
Eclinicalmedicine|June 16, 2025
Defining benchmark values for outcomes of comprehensive resection of primary retroperitoneal liposarcoma: a retrospective multicenter studyFabio Tirotta, Marco Fiore, Sylvie Bonvalot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWGChandrajit P Raut, Dario Callegaro, Rosalba Miceli, et al.
Annals of Surgical Oncology|January 3, 2021
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Pageof 43